Home  |  Contact

UniProtKB/Swiss-Prot P51449: Variant p.Ser38Leu

Nuclear receptor ROR-gamma
Gene: RORC
Variant information

Variant position:  38
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Serine (S) to Leucine (L) at position 38 (S38L, p.Ser38Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and polar (S) to medium size and hydrophobic (L)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Immunodeficiency 42 (IMD42) [MIM:616622]: An autosomal recessive primary immunodeficiency characterized by increased susceptibility to concomitant candidiasis and mycobacteriosis. Candidiasis is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida. Mycobacteriosis is characterized by infections caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. IMD42 patients vaccinated with BCG are particularly at risk for developing disseminated mycobacterial infections. {ECO:0000269|PubMed:26160376}. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In IMD42; does not affect nuclear localization; loss of transcription regulatory region sequence-specific DNA binding; loss of transcriptional activity.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.

Sequence information

Variant position:  38
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  518
The length of the canonical sequence.

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.



Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 1 – 518 Nuclear receptor ROR-gamma
DNA binding 31 – 96 Nuclear receptor
Zinc finger 31 – 51 NR C4-type

Literature citations

Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.
Okada S.; Markle J.G.; Deenick E.K.; Mele F.; Averbuch D.; Lagos M.; Alzahrani M.; Al-Muhsen S.; Halwani R.; Ma C.S.; Wong N.; Soudais C.; Henderson L.A.; Marzouqa H.; Shamma J.; Gonzalez M.; Martinez-Barricarte R.; Okada C.; Avery D.T.; Latorre D.; Deswarte C.; Jabot-Hanin F.; Torrado E.; Fountain J.; Belkadi A.; Itan Y.; Boisson B.; Migaud M.; Arlehamn C.S.; Sette A.; Breton S.; McCluskey J.; Rossjohn J.; de Villartay J.P.; Moshous D.; Hambleton S.; Latour S.; Arkwright P.D.; Picard C.; Lantz O.; Engelhard D.; Kobayashi M.; Abel L.; Cooper A.M.; Notarangelo L.D.; Boisson-Dupuis S.; Puel A.; Sallusto F.; Bustamante J.; Tangye S.G.; Casanova J.L.;
Science 349:606-613(2015)

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.